OBJECTIVES: The goal of this study was to verify the association between type 1 diabetes (T1D) and the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene in non-Hispanic whites (NHWs) and Hispanics from Colorado. SUBJECTS AND METHODS: The C1858T single-nucleotide polymorphism within the PTPN22 gene was genotyped in 753 patients with T1D ascertained from the diabetes clinic at the Barbara Davis Center in Denver and 662 control population. RESULTS: Both the PTPN22 CT genotype [odds ratio (OR) = 1.96; p < 0.0001] and TT genotype (OR = 4.41; p = 0.02) were significantly associated with T1D in the NHW population. While the association was stronger in subjects with non-HLA-DR3/4 genotypes than in those with the HLA-DR3/4 genotype, regression analyses did not reveal significant interaction between PTPN22 genotypes and HLA-DR3/4. The strength of the association was similar in males and females, patients diagnosed before and after age 10 yr, and in Hispanics and NHWs. CONCLUSION: In this study, we confirm that PTPN22 is associated with T1D in the Colorado population.
OBJECTIVES: The goal of this study was to verify the association between type 1 diabetes (T1D) and the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene in non-Hispanic whites (NHWs) and Hispanics from Colorado. SUBJECTS AND METHODS: The C1858T single-nucleotide polymorphism within the PTPN22 gene was genotyped in 753 patients with T1D ascertained from the diabetes clinic at the Barbara Davis Center in Denver and 662 control population. RESULTS: Both the PTPN22 CT genotype [odds ratio (OR) = 1.96; p < 0.0001] and TT genotype (OR = 4.41; p = 0.02) were significantly associated with T1D in the NHW population. While the association was stronger in subjects with non-HLA-DR3/4 genotypes than in those with the HLA-DR3/4 genotype, regression analyses did not reveal significant interaction between PTPN22 genotypes and HLA-DR3/4. The strength of the association was similar in males and females, patients diagnosed before and after age 10 yr, and in Hispanics and NHWs. CONCLUSION: In this study, we confirm that PTPN22 is associated with T1D in the Colorado population.
Authors: M Maziarz; M Janer; J C Roach; W Hagopian; J P Palmer; K Deutsch; C B Sanjeevi; I Kockum; N Breslow; A Lernmark Journal: Genes Immun Date: 2010-05-06 Impact factor: 2.676
Authors: Siyang Liu; Hongjie Wang; Yulan Jin; Robert Podolsky; M V Prasad Linga Reddy; Jennifer Pedersen; Bruce Bode; John Reed; Dennis Steed; Steve Anderson; Ping Yang; Andy Muir; Leigh Steed; Diane Hopkins; Yihua Huang; Sharad Purohit; Cong-Yi Wang; Andrea K Steck; Annalisa Montemari; George Eisenbarth; Marian Rewers; Jin-Xiong She Journal: Hum Mol Genet Date: 2008-10-16 Impact factor: 6.150
Authors: A Blasetti; C Di Giulio; S Tumini; M Provenzano; D Rapino; L Comegna; G Prezioso; R Chiuri; S Franchini; F Chiarelli; L Stuppia Journal: Pharmacogenomics J Date: 2016-02-23 Impact factor: 3.550
Authors: A K Steck; E E Baschal; J M Jasinski; B O Boehm; N Bottini; P Concannon; C Julier; G Morahan; J A Noble; C Polychronakos; J X She; G S Eisenbarth Journal: Genes Immun Date: 2009-12 Impact factor: 2.676